Hair restoration sits at an unusual intersection of dermatology, surgery, and regenerative medicine. For most of the past two decades the category attracted limited industry attention in India, growing in pockets rather than as a structured specialty. That has changed. The discipline has matured into a recognisable healthcare segment with consolidating clinical standards, identifiable centres of excellence, and a…
THOUGHTSPOT
The pharma market access conferences worth a commercial team's time in 2026 share one trait: they put market access, HEOR, and medical affairs leaders in the same room as the payers and health system executives who actually control access.
Reaching prescribers is not the same as winning system adoption, and the events below are where that second, harder conversation…
AI has moved beyond proof-of-concept on the clinical side of pharma, driving rapid discovery of new molecules. But post-market commercialization teams tell a different story: their boards are asking them to use AI to solve the problems caused by multiple rounds of layoffs, mounting pressure to do more with less, and a human capital fabric…
Everyone wants faster hair growth — especially when a bad haircut or noticeable thinning leaves you anxious to see change. So it's no surprise that searches like "how to grow hair faster in a week" spike constantly. But before you stock up on oils, supplements, and miracle serums, it helps to understand what hair growth actually looks like from a biological standpoint.…
The oncology landscape is increasingly recognizing that the future of cancer treatment may depend just as much on immune engagement and combination strategies as on standalone therapeutic activity.
That shift in thinking is shaping much of the scientific attention surrounding pelareorep, the lead immunotherapeutic candidate being advanced by Oncolytics (NASDAQ: ONCY).
For years, oncology drug candidates were largely evaluated through…
Biotech innovation is rapidly transforming the boundaries of modern wellness, and CEAS Collective stands at the forefront of this shift. By integrating advanced product development with a direct-to-patient delivery model, CEAS Collective bridges the gap between next-generation health solutions and consumer-centric care. Their approach sets a new benchmark for accessible, holistic wellness, offering patients seamless access to science-driven products…
Hospitals strive for revenue, much like sailors seeking a clear tide. Most stare at tariffs, contracts, and shiny new billing tools. The clever ones start somewhere far less glamorous. The humble clinical note. Every charge, every quality metric, every audit trail balances on that single piece of text. A careless note drains the organization's finances…
Author: Jehee Suh, CEO, Inocras
Breast cancer is not one disease. It’s a set of biologically distinct malignancies that differ by subtype, clinical behavior, and most importantly, how patients respond to therapy. Over the past two decades, oncology has made real progress by aligning treatment to a handful of established biomarkers (ER/PR, HER2, BRCA1/2). Despite…
The pharmaceutical industry is undergoing a fundamental shift in how supply chains are managed. As products become more complex – biologics, cell and gene therapies, temperature-sensitive vaccines – the margin for error in logistics shrinks to near zero.
Traditional monitoring approaches, built around passive data loggers and post-delivery analysis, are no longer sufficient. Today's pharma…
Many health care organizations must hire swiftly. Long-term vacancies harm operations and trust by reducing staff, increasing patient volume, and overworking doctors. There are problems with quick hiring. Doing things quickly can worsen them. Poor healthcare puts people at risk, hurts teams, and hurts the company's image.
Leaders in medical recruitment must think long-term. Hiring…

